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ABSTRACT 
Foodborne disease caused by Escherichia coli contamination is increasing every year. It also followed 
by elevating of drug-resistance of E. coli. Bacteriophage can be an alternative for therapy infection.  This 
study aimed to determine synergism effect of bacteriophage ϕPT1b which has a high rate virulence to E. 
coli and phage-antibiotics (tetracycline and amoxicillin) synergy. The indigenous bacteria isolates were 
KR, MJ, KP, PT, PR. Five bacteriophages used namely ϕKR1b, ϕKR2, ϕPT1a, ϕPT1b, and ϕMJ1b. 
Virulence test was used to determine the ability of each phage in reducing E. coli. Treatment to examine 
synergism of phage ϕPT1b and antibiotics were P1: amoxicillin, P2: ϕPT1b, P3: ϕPT1b + Amx = 1:1, P4 : 
ϕPT1b + Amx = 2:1, P5: ϕPT1b + Amx = 1:2, P6 : tetracycline, P2: ϕPT1b, P7: ϕPT1b + Tet = 1:1, P8 : 
ϕPT1b + Tet = 2:1, and P9: ϕPT1b + Tet = 1:2. The virulence test showed that isolate ϕPT1a with 106 
CFU/ml had the highest ability in reducing E. coli. While, the result of synergism test indicated that the 
synergism of bacteriophage and antibiotics differ significantly (P ≤ 0.05). The best ratios of synergism were 
1:1 (ϕPT1b+tetracycline) and 2:1 (ϕPT1b+amoxicilline). In summarize, phage-antibiotic synergy (ϕPT1b 
with tetracycline/amoxicilline) can reduce the level of antibiotic resistance in isolated E. coli. 
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INTRODUCTION 
Foodborne disease is caused by 
contaminated food consumption. 
Contamination happens during preparation and 
serving process; it poses threats to health in 
general (Ameme et al.,  2016). One type of food 
prone to bacterial contamination is vegetables 
(Quinlan, 2013). Campylobacter (Verhoeff-
Bakkenes et al., 2011; Mohammadpour et al., 
2018), Salmonella (de Freitas Neto et al., 2010; 
Golberg et al., 2011), Shigella (Ranjbar et al., 
2010; Magnone et al., 2013), Listeria (Ponniah 
et al., 2010; Oliveira et al., 2011), Yersinia 
(Xanthopoulos et al., 2010; Tirziu et al., 2011) 
and Escherichia coli (Harapas et al., 2010; 
Ijabadeniyi et al., 2011; Uzeh & Adepoju, 
2013) are among the common bacteria 
contaminate vegetables. 
Pathogenic E. coli are the dominant cause 
of diarrhea which is the primary indicator of 
food poisoning.The symptoms can be severe 
and fatal. Diarrhea-caused E. coli can be 
divided into several types, including 
enterotoxic E. coli (ETEC), enteropathogenic 
E. coli (EPEC), enteroinvasive E. coli (EIEC), 
and enterohaemorrhagic E. coli (EHEC). In 
addition, a uropathogenic E. coli can infect 
extraintestinal and causing urinary tract 
infections. Some of these strains can cause 
foodborne disease (Caine et al., 2014). 
Typical treatment for foodborne disease is 
using antibiotics, but now antibiotics pose a 
new problem, which is an increase in the 
incidence of antibiotics resistance. Antibiotic 
resistance is characterized by failure inhibition 
of bacterial growth (Andersson & Hughes, 
2010; Humaida, 2014; Brown & Wright, 2016).  
E. coli show antibiotic resistance in all β-lactam 
antibiotics, tetracycline, and in cephalothin and 
cefoxitin from cephalosporins (Sidik et al., 
2016). Another alternative treatment for 
foodborne disease is using bacteriophages 
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(phages). Bacteriophage is a virus that can 
infect and kill bacterial cells. The presence of 
bacteriophages that can kill these hosts can be 
applied in the technology of the lytic process for 
biofilm-forming bacteria (Buana & Wardani, 
2013). Bacteriophages have a tiny size, in 
nanometers, and live in the same place as the 
bacterial host. Bacteriophages have species-
specific properties and even in strains that can 
only infect bacteria that are like their hosts 
(Hamdi et al., 2017). 
Phage therapy has proven effective for 
controlling pathogens that cause foodborne 
disease both pre- and post-harvest. 
Administration of phages in pre- and post-
harvest can control the contamination of 
bacteria such as E. coli O157: H7, Salmonella, 
and Campylobacter in food products. The use 
of phages in pre-harvest to reduce pathogens is 
carried out directly by providing phages to the 
plants, while the administration of phages in the 
post-harvest is carried out directly to eliminate 
unwanted contaminants in food products that 
are ready to be consumed (Teng-Hern et al., 
2014). 
Phages as biocontrol have several 
advantages such as the ability to attack bacteria 
and zero influence on other cell types including 
human, animal and plant cells. This is as 
reported in the ϕECP100 and ϕAHFAHEc1 
tests carried out as natural preservatives of fresh 
vegetables and meat products contaminated by 
E. coli O157: H7. Test results showed that 
bacteriophage ϕECP100 and ϕAHFAHEc1 
could eliminate contamination of E. coli in raw 
beef (Lee et al., 2017) . In other studies, 
ϕVCEV1 can also infect E. coli O157: H7 
where this bacteriophage has a 70 nm 
icosahedral head shape and a long flexible tail 
measuring 175 nm in length and 10 nm in width 
with a genome size of 120 kb (Raya et al., 
2015). 
Another advantage of bacteriophages is 
that it can reduce the resistance of pathogenic 
bacteria to antibiotics. Combinations between 
bacteriophages and antibiotics usually referred 
to as phage-antibiotic synergy (PAS). In ϕKS12 
and ϕKS14 with a combination of 
ciprofloxacin, meropenem, and tetracycline can 
kill Burkholderia cepacia thus it can reduce the 
resistance properties of Burkholderia cepacia 
against antibiotics (Kamal & Dennis, 2015; 
Sfeir, 2018). In a previous study, isolated five 
bacteriophages from E. coli contaminating 
vegetables in the Jember Regency (Narulita et 
al., 2018). The five bacteriophages have not 
been known of the ability to perform PAS 
including bacteriophage ϕPT1a that have a high 
virulence rate. This study aimed to determine 
synergism effect of bacteriophage ϕPT1a which 
has a high rate virulence to E. coli and phage-
antibiotics (tetracycline and amoxicillin) 
synergy. 
 
MATERIALS AND METHODS 
Sample Preparation. Bacteria were 
grown in eosin methylene blue agar (EMBA) to 
determine whether the bacteria used were 
isolates of Escherichia coli PT (Tanjung 
Market), KR (Kreongan Market), MJ (Peddler), 
KP (Kepatihan Market), PR (Patrang Market). 
In EMBA, E. coli PT (Tanjung Market), KR 
(Kreongan Market), MJ (Peddler), KP 
(Kepatihan Market), PR (Patrang Market) give 
characteristics of metallic green colonies.  For 
further treatment luria bertani (LB) medium 
was used. The incubation was carried out for 24 
hours at 37°C. Particles of phages were 
multiplied by plaque assay techniques 
following. A 100 μl of each filtrate 
bacteriophage of  ϕKR1a, ϕKR1b, ϕPT1a, 
ϕPT1b, ϕMJ1b and ϕKR2 suspension added 
into 250 μl of E. coli suspension which had 
been incubated for 2 hours at 37°C. The 
suspension was mixed with warm (around 
50°C) top agar medium, and then poured on 
LB. The petri dish was incubated at 37°C for 24 
hours. The colonies of phage were indicated in 
the formation of plaques. SM buffers as much 
as 5 ml were added to acquire the phages. The 
media were shaken for 4 hours at 4°C and then 
were centrifuged for 10 minutes at 10000 rpm. 
The phages were harvested using a membrane 
filter with a pore membrane density of 0.2 µm. 
The filtrate served as bacteriophage stock 
(Askora et al., 2009). 
Virulence Assay. The test was carried out 
using the plaque assay technique (Askora et al., 
2009). A 300 µl suspension of 5 hours E. coli 
and, 3 µl phage suspension was added to the 






























0.3% warm top medium. The mixture then was 
poured on the surface of LB agar media in a 
petri dish (double layer method). Incubation 
carried out at 37°C for 24 hours. The growth of 
phages was observed by counting the formation 
of plaque. Different concentrations were used 
for each type of phage suspension i.e 102, 104, 
and 106 of phages suspension. 
Virulence Assay of phage + antibiotic to 
the growth of E. coli. The technique to find out 
the strength of phage+antibiotic virulence was 
using spot test technique according to (Narulita 
et al., 2018). A 300 µl suspension of 5 hours E. 
coli (0.1 U of OD600) and 3 µl bacteriophage 
suspension was added to the 0.3% warm top 
medium. The mixture then was poured on the 
surface of LB agar medium in a petri dish 
(double layer method). Next, 3 µl of the 
phage+3 µl antibiotic suspension was spotted 
on the LB agar medium and incubated at 37°C 
for 24 hours. Growth was observed with the 
formation of plaque with six replications. Serial 
of phage concentration was used which gave 
the maximum results in the previous test 
(virulence test without antibiotics). 
Bacteriophages used in the phage-
antibiotic synergy (PAS) test was ϕPT1a that 
has a highest virulence rate in infecting E. coli 
isolates. The antibiotics used were amoxicillin 
(Amx) and tetracycline (Tet). The treatment 
was divided into P1: amoxicillin, P2: ϕPT1b, 
P3: ϕPT1b + Amx = 1:1, P4 : ϕPT1b + Amx = 
2:1, P5: ϕPT1b + Amx = 1:2, P6 : tetracycline, 
P2: ϕPT1b, P7: ϕPT1b + Tet = 1:1, P8 : ϕPT1b 
+ Tet = 2:1, and P9: ϕPT1b + Tet = 1:2. The 
effect of this test results determined by analysis 
of variants (ANOVA) of 95% confidence level 
(p <0.05), then followed by Duncan's test. 
 
RESULT AND DISCUSSION 
Each phage has different virulence 
abilities. From three different phage 
concentrations of 102, 104, 106 (CFU/ml) of 
each tested bacteriophage, ϕPT1b gave the 
highest result of infection to E. coli at 
concentration of 106 CFU/ml (Figure 1 and 2) 
















Figure 1. The number of phage on plaque assay with Escherichia coli 
 
The combination between phage and 
amoxicillin showed different results that in 
treatment P4 gave higher efficiency than the 
others, P2 had a higher level of infection than 
amoxicillin whereas P7 was a combination of 
phage and tetracycline indicating that P7 had a 
higher effectiveness (Table 1 and 2). 
Virulence test used amoxicillin and 
tetracycline because both types of antibiotics 
performed resistance to E. coli. In the treatment 
area that only used antibiotics, no plaque was 
formed. This result showed no growth 
inhibition in E. coli (resistance occurred). The 
resistance occurs due to biochemical 
modifications that alter the nature of bacteria 
from those that are usually sensitive to 
antibiotics to become insensitive.
 












Figure 2. Virulence test results of phage combination: a. amoxicillin antibiotics with treatment P1: amoxicillin, P2: 
ϕPT1b, P3: ϕPT1b + Amx = 1:1, P4 : ϕPT1b + Amx = 2:1, P5: ϕPT1b + Amx = 1:2; b. tetracyclin with treatment 
P6 : tetrasiklin, P2: ϕPT1b, P7: ϕPT1b + Tet = 1:1, P8 : ϕPT1b + Tet = 2:1, P9: ϕPT1b + Tet = 1:2. 
 
The chemical modification that occurs can 
be an enzyme that deactivates antibiotic 
receptors and changes in protein in the cell wall 
that inhibit the absorption of these antibiotics. 
The existence of genetic mechanisms in the 
form of mutations and transformations can also 
trigger antibiotic resistance. Mutations may 
occur naturally during cell division. The more 
cells undergo replication, the higher the chance 
for mutation. Mutations that occur may encode 
a new resistance gene to deactivate antibiotic 
receptors (Andersson & Hughes, 2014; Blount, 
2015). Plaque can be found in the treatment 
area that uses a combination of antibiotics and 
phages (Figure 2). On the other hand, the 
bacteriophage virulence test showed that 
ϕPT1b was able to infect bacteria higher than 
the other phages at a concentration of 106 
CFU/ml (Figure 1).
 
Table 1. The result of virulence assay for phage + amoxicillin combination to E. coli 
Treatments Average of Plaque Diameter (mm) 
P1 0.00 ± 0.0a 
P2 1.50 ± 0.22c 
P3 1.31 ± 0.29bc 
P4 1.41 ± 0.21bc 
P5 1.19± 0.14b 
K- 0.00 ± 0.0 
Notes: P1 : amoxicillin (Amx), P2 : ϕPT1b, P3 : Phage + Amx= 1:1, P4 : Phage + Amx= 2:1, P5: Phage + Amx= 1:2. The same letter in the same 
column indicates not significantly different by Duncan test using α 5% 
 
Table 2. The result of virulence assay for phage + tetracyclin combination to E. coli 
Treatments Average of Plaque Diameter (mm) 
P6 0.00 ± 0.00a 
P2 1.50 ± 0.22c 
P7 1.36 ± 0.21b 
P8 1.30 ± 0.12b 
P9 1.23 ± 0.25b 
K- 0.00 ± 0.00 
Notes: P2 : ϕPT1b, P6 : Tetracyclin (Tet), P7 : Phage + Tet = 1:1, P8 : Phage + Tet = 2:1, P9 : Phage + Tet = 1:2. The same letter in the same column 
indicates not significantly different by Duncan test using α 5% 
 
The results of virulence test of phage-
antibiotics combinations gave different results 
between the two types of antibiotics. The 
treatment of P2, P3, P4, P5, P7, P8 and P9 were 
significantly different from P1 and P6 (Table 1 
and Table 2). In the combination of phage with 
amoxicillin, it showed that P4 gave higher 
virulence effectiveness than P3 and P5 (Table 
1). While the combination of phage with 
tetracycline indicated that the P7 treatment has 
higher effectiveness compared to P8 and P9 
(Table 2). P2 treatment which was phage 
a b 
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ϕPT1b only, it turned out to have the highest 
infection rate compared to the combination 
with amoxicillin and tetracycline (Table 1 and 
2). Large clear zones formed for both types of 
antibiotic combinations can be seen in Figure 2.  
The difference in plaque size is due to the 
replication process of phages that produce new 
plaques (Bhardwaj et al., 2015). The more 
phages produced will have larger plaque sizes, 
and vice versa, if the fewer phages are 
produced, then the size plaque will get smaller 
too. The resulting plaque size is determined by 
the number of virions produced in each infected 
cell and how long it takes for bacteriophages to 
lyse infected cells (Comeau et al., 2007).   
When phages and antibiotics are 
combined, there is a possibility of phage mutant 
that lyses bacteria faster and can make plaque 
formation more quickly than the parent 
bacteriophage. Antibiotics also have the same 
working time as bacteriophages, hence a 
combination of bacteriophages and antibiotics 
can inhibit the growth of pathogenic bacterial 
cells (Golkar et al., 2014; Tagliaferri et al., 
2019). Similar research was conducted, 
regarding bacteriophage therapy to control 
pathogenic Pseudomonas aeruginosa by 
combining antibiotics and bacteriophages 
(Torres-Barceló et al., 2014). The results 
showed that the combination of streptomycin 
and bacteriophages results in a positive synergy 
that inhibits the growth of Pseudomonas 
aeruginosa. T4 type phages could also be 
combined with cefotaxime type antibiotics 
Comeau et al. (2007) found there was positive 
synergy marked by the reduction of E. coli cell 
production. The presence of phage-antibiotic 
synergy (PAS) response is seen with the 
formation of clear zones which indicate that 
chemicals in antibiotics stimulate phage growth 
at the same level as the conditions of antibiotics 
when inhibiting bacterial cell division. 
 
CONCLUSION 
Phage-antibiotic synergy (ϕPT1b with 
tetracycline/amoxicilline) can reduce the level 
of antibiotic resistance in isolated E. coli. 
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